ProQR Therapeutics NV
NASDAQ:PRQR

Watchlist Manager
ProQR Therapeutics NV Logo
ProQR Therapeutics NV
NASDAQ:PRQR
Watchlist
Price: 1.74 USD 2.35% Market Closed
Market Cap: 183.1m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+6%
Revenue
Forecast
+35%
Operating Income
Forecast
+26%
Net Income
Forecast
-4%

Wall Street
Price Targets

PRQR Price Targets Summary
ProQR Therapeutics NV

Wall Street analysts forecast PRQR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PRQR is 10.46 USD with a low forecast of 4.04 USD and a high forecast of 15.75 USD.

PRQR Lowest Forecast
Wall Street Target
4.04 USD
132% Upside
PRQR Average Forecast
Wall Street Target
10.46 USD
501% Upside
PRQR Highest Forecast
Wall Street Target
15.75 USD
805% Upside
Lowest
Price Target
4.04 USD
132% Upside
Average
Price Target
10.46 USD
501% Upside
Highest
Price Target
15.75 USD
805% Upside
ProQR Therapeutics NV Competitors:
Price Targets
ORKA
Oruka Therapeutics Inc
243% Upside
ELDN
Eledon Pharmaceuticals Inc
243% Upside
INSM
Insmed Inc
41% Upside
RNA
Avidity Biosciences Inc
115% Upside
ORKA
Oruka Therapeutics Inc
243% Upside
ELDN
Eledon Pharmaceuticals Inc
243% Upside
INSM
Insmed Inc
41% Upside
RNA
Avidity Biosciences Inc
115% Upside
INCY
Incyte Corp
14% Upside
BNTX
BioNTech SE
38% Upside
S
096530
Seegene Inc
27% Upside
300653
Yantai Zhenghai Bio-Tech Co Ltd
37% Upside

Revenue
Forecast

Revenue Estimate
ProQR Therapeutics NV

For the last 11 years the compound annual growth rate for ProQR Therapeutics NV's revenue is 59%. The projected CAGR for the next 3 years is -23%.

59%
Past Growth
-23%
Estimated Growth
Estimates Accuracy
-4%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
ProQR Therapeutics NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
9%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
ProQR Therapeutics NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-61%
Average Miss
What are analyst estimates?

See Also

Summary
PRQR intrinsic value, competitors valuation, and company profile.
DCF Valuation
PRQR stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PRQR stock valuation using valuation multiples.
Wall Street Estimates
PRQR price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PRQR stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PRQR's stock price target?
Price Target
10.46 USD

According to Wall Street analysts, the average 1-year price target for PRQR is 10.46 USD with a low forecast of 4.04 USD and a high forecast of 15.75 USD.

What is ProQR Therapeutics NV's Revenue forecast?
Projected CAGR
-23%

For the last 11 years the compound annual growth rate for ProQR Therapeutics NV's revenue is 59%. The projected CAGR for the next 3 years is -23%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 258,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.